ロード中...
Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials
BACKGROUND: The purpose of this study was to evaluate the intraocular pressure (IOP)-lowering efficacy and safety of bimatoprost 0.01% or 0.03% as monotherapy in patients treated with latanoprost 0.005% monotherapy who require additional IOP lowering for their ocular hypertension or open-angle glauc...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3971936/ https://ncbi.nlm.nih.gov/pubmed/24707169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S59197 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|